Effects of Secondary Plant Metabolites on Human Health
A special issue of Metabolites (ISSN 2218-1989). This special issue belongs to the section "Plant Metabolism".
Deadline for manuscript submissions: 15 October 2025 | Viewed by 677
Special Issue Editors
Interests: secondary plant metabolites; polyphenols; antioxidants; public health
Special Issue Information
Dear Colleagues,
Plant species must synthesize many chemical compounds—phytochemicals—to ensure survival. Most of these compounds are classified as secondary plant metabolites. The synthesis of phytochemicals is highly dependent on the growth conditions of plant species. Consequently, nature provides us with an enormous number of chemical compounds with significant structural variety. Since its beginnings, humanity has used medicinal plants whose positive effects are due to the presence of some secondary metabolites. There is a tradition of obtaining antitumor compounds from plant species, such as taxol from Taxus brevifolia or vinca alkaloids from Catharanthus roseus, or anti-inflammatory and antioxidative compounds such as flavones from Heterotheca inuloides. As it is known that anti-inflammatory processes are intricately linked to the onset of tumor processes, studying plant-derived compounds to better understand their functions and mechanisms of action is essential, representing an exciting area of research with a wide range of applications. Your research in this area has the potential to significantly impact human health, and we invite you to publish your latest findings in this Special Issue dedicated to secondary plant metabolites related to human health.
Dr. Beáta Čižmárová
Dr. Anna Birková
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Metabolites is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- human health
- inflammation
- cancer
- obesity
- antioxidants
- phytochemicals
- phytoestrogens
- secondary metabolites
- natural products
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
